Boxer Capital, LLC’s Cullinan Therapeutics Inc Position
Does Boxer Capital, LLC own Cullinan Therapeutics Inc (CGEM)? Not currently — the last reported position was 907.9K shares worth $15M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$15M
Q3 2024
Shares
907.9K
% of Portfolio
+0.75%
Quarters Held
13
position exited
Position History CGEM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 907.9K | $15M | +0.75% |
| Q2 2024 | 657.9K | $11M | +0.60% |
| Q3 2023 | 1.07M | $10M | +0.52% |
| Q2 2023 | 1.07M | $11,557 | +0.54% |
| Q1 2023 | 1.07M | $10,988 | +0.54% |
| Q4 2022 | 1.07M | $11M | +0.60% |
| Q3 2022 | 1.07M | $14M | +0.77% |
| Q2 2022 | 1.07M | $14M | +0.87% |
| Q1 2022 | 1.07M | $11M | +0.58% |
| Q4 2021 | 1.07M | $17M | +0.64% |
| Q3 2021 | 1.07M | $24M | +0.85% |
| Q2 2021 | 1.07M | $28M | +0.98% |
| Q1 2021 | 1.07M | $45M | +1.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of CGEM.